Melanoma

Density of immunogenic antigens does not explain presence or absence of the T cell-inflamed tumor microenvironment in metastatic melanoma
Yuanyuan Zha, Stefani Spranger, Kyle M Hernandez, Yan Li, Riyue Bao, Peter Alexieff, Jorge Andrade, Jason J Luke, Thomas F Gajewski

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P425; DOI: 10.1186/2051-1426-3-S2-P425
High frequency CD8+PD-1+ TCR clonotypes isolated from fresh melanomas display anti-tumor activity
Pasetto Anna, Alena Gros, Paul F Robbins, Todd D Prickett, Drew C Deniger, Rodrigo Matus-Nicodemus, Maria R Parkhurst, Jessica S Crystal, Kasia Trebska-Mcgowan, Steven A Rosenberg

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P42; DOI: 10.1186/2051-1426-3-S2-P42
Diversity of mutated antigen recognition by tumor infiltrating lymphocytes from patients with metastatic melanoma
Jessica S Crystal, Todd D Prickett, Jared J Gartner, Maria R Parkhurst, Yong-Chen Lu, Alena Gros, Yong Li, Kasia Trebska-Mcgowan, Mona El-Gamil, Steven A Rosenberg, Paul F Robbins

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P9; DOI: 10.1186/2051-1426-3-S2-P9
Functional antigen presenting cells generated from human dendritic cells (DC) derived induced pluripotent stem cell lines
Arvind Chhabra

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P206; DOI: 10.1186/2051-1426-3-S2-P206
Safety data of Montanide ISA 51 VG and Montanide ISA 720 VG, two adjuvants dedicated to human therapeutic vaccines
Stephane Ascarateil, Aude Puget, Marie-Eve Koziol

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P428; DOI: 10.1186/2051-1426-3-S2-P428
Combined killing of cancer cells and cross presentation of tumor antigen by Vγ9Vδ2 T cells
Gitte Holmen Olofsson, Manja Idorn, Ramona Schenker, Elfriede Nössner, Reno Debets, Bernhard Moser, Özcan Met, Per thor Straten

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P327; DOI: 10.1186/2051-1426-3-S2-P327
Multispectral imaging and objective assessment of immune-tumor interactions in non-small cell lung cancer
Carmen Ballesteros-Merino, Michael Neuberger, Zipei Feng, Rudolf Maria Huber, Julia Stump, Amanda Tufman, Rudolf Hatz, Michael Linder, Rachel Sanborn, Sanaa Hussain, John R Handy, Walter Urba, Bernard Fox, Carlo Bifulco, Simone Reu, Hauke Winter

Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P394; DOI: 10.1186/2051-1426-3-S2-P394
Stable disease after high dose interleukin-2 (HD IL-2) immunotherapy: observations on long term survival and clinical benefit of additional HD IL-2
Howard L Kaufman, Sandra Aung, Michael Morse, Michael Wong, James Lowder, Gregory Daniels, David McDermott

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P88; DOI: 10.1186/2051-1426-2-S3-P88
Isolation of T cell receptors specifically reactive with mutated tumor associated antigens
Maria Parkhurst, Paul Robbins, Steven Rosenberg

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P33; DOI: 10.1186/2051-1426-2-S3-P33
Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)
F Stephen Hodi, Antoni Ribas, Adil Daud, Omid Hamid, Caroline Robert, Richard Kefford, Wen-Jen Hwu, Tara C Gangadhar, Anthony M Joshua, Peter Hersey, Jeffrey Weber, Richard W Joseph, Hassane Zarour, Roxana Dronca, Linda Gammage, Darcy Hille, Dahai Xue, S Peter Kang, Patrick Chun, Scot W Ebbinghaus, Andrea Perrone, Jedd D Wolchok

Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P103; DOI: 10.1186/2051-1426-2-S3-P103

Main menu

Melanoma

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Melanoma

Pages